251 related articles for article (PubMed ID: 23792963)
21. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
Li Z; Baidoun R; Brown AC
Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
[TBL] [Abstract][Full Text] [Related]
22. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol.
Boesze-Battaglia K; Brown A; Walker L; Besack D; Zekavat A; Wrenn S; Krummenacher C; Shenker BJ
J Biol Chem; 2009 Apr; 284(16):10650-8. PubMed ID: 19240023
[TBL] [Abstract][Full Text] [Related]
23. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
[TBL] [Abstract][Full Text] [Related]
24. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
Kachlany SC; Schwartz AB; Balashova NV; Hioe CE; Tuen M; Le A; Kaur M; Mei Y; Rao J
Leuk Res; 2010 Jun; 34(6):777-85. PubMed ID: 19747730
[TBL] [Abstract][Full Text] [Related]
25. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells.
Lally ET; Golub EE; Kieba IR
J Biol Chem; 1994 Dec; 269(49):31289-95. PubMed ID: 7983074
[TBL] [Abstract][Full Text] [Related]
26. Aggregatibacter actinomycetemcomitans leukotoxin induces cytosol acidification in LFA-1 expressing immune cells.
Balashova N; Dhingra A; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2016 Feb; 31(1):106-14. PubMed ID: 26361372
[TBL] [Abstract][Full Text] [Related]
27. Characterization of putative cholesterol recognition/interaction amino acid consensus-like motif of Campylobacter jejuni cytolethal distending toxin C.
Lai CH; Lai CK; Lin YJ; Hung CL; Chu CH; Feng CL; Chang CS; Su HL
PLoS One; 2013; 8(6):e66202. PubMed ID: 23762481
[TBL] [Abstract][Full Text] [Related]
28. The Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Active Subunit CdtB Contains a Cholesterol Recognition Sequence Required for Toxin Binding and Subunit Internalization.
Boesze-Battaglia K; Walker LP; Zekavat A; Dlakić M; Scuron MD; Nygren P; Shenker BJ
Infect Immun; 2015 Oct; 83(10):4042-55. PubMed ID: 26216427
[TBL] [Abstract][Full Text] [Related]
29. Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.
Balashova NV; Diaz R; Balashov SV; Crosby JA; Kachlany SC
J Bacteriol; 2006 Dec; 188(24):8658-61. PubMed ID: 17041062
[TBL] [Abstract][Full Text] [Related]
30.
Lally ET; Boesze-Battaglia K; Dhingra A; Gomez NM; Lora J; Mitchell CH; Giannakakis A; Fahim SA; Benz R; Balashova N
Pathogens; 2020 Jan; 9(2):. PubMed ID: 31973183
[TBL] [Abstract][Full Text] [Related]
31. Disorder in cholesterol-binding functionality of CRAC peptides: a molecular dynamics study.
Miller CM; Brown AC; Mittal J
J Phys Chem B; 2014 Nov; 118(46):13169-74. PubMed ID: 25347282
[TBL] [Abstract][Full Text] [Related]
32. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Bacterial Toxin Activity by the Nuclear Stain, DRAQ5™.
Webb JN; Koufos E; Brown AC
J Membr Biol; 2016 Aug; 249(4):503-11. PubMed ID: 27039399
[TBL] [Abstract][Full Text] [Related]
34. Leukotoxin (LtxA/Leukothera) induces ATP expulsion via pannexin-1 channels and subsequent cell death in malignant lymphocytes.
Prince DJ; Patel D; Kachlany SC
Sci Rep; 2021 Sep; 11(1):18086. PubMed ID: 34508147
[TBL] [Abstract][Full Text] [Related]
35. Characterization of leukotoxin from a clinical strain of Actinobacillus actinomycetemcomitans.
Diaz R; Ghofaily LA; Patel J; Balashova NV; Freitas AC; Labib I; Kachlany SC
Microb Pathog; 2006 Feb; 40(2):48-55. PubMed ID: 16414241
[TBL] [Abstract][Full Text] [Related]
36. Purification of secreted leukotoxin (LtxA) from Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Protein Expr Purif; 2002 Aug; 25(3):465-71. PubMed ID: 12182827
[TBL] [Abstract][Full Text] [Related]
37. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
Sampathkumar V; Velusamy SK; Godboley D; Fine DH
Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
[TBL] [Abstract][Full Text] [Related]
38. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway.
DiFranco KM; Gupta A; Galusha LE; Perez J; Nguyen TK; Fineza CD; Kachlany SC
J Biol Chem; 2012 May; 287(21):17618-17627. PubMed ID: 22467872
[TBL] [Abstract][Full Text] [Related]
39. RTX Toxins Ambush Immunity's First Cellular Responders.
Ristow LC; Welch RA
Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31835552
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
